Sitagliptin (JANUVIA)
Dipeptidyl Peptidase 4 Inhibitor class · 3 generic manufacturers · 9 ANDAs filed at FDA.
$4.88B in CY2024 Part D spend6.0M claims · 1.5M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Sitagliptin used for?
Sitagliptin is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Sitagliptin?
Yes. 9 ANDAs filed at FDA, 3 generic manufacturers currently shipping.
How much does my plan pay for Sitagliptin?
Across 329 Part D plans, Sitagliptin averages $10.44/unit (NADAC). Lowest available: $10.05/unit. Highest in distribution: $10.55/unit.
Is Sitagliptin on the FDA shortage list?
No. Sitagliptin is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (13 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.